A team of Canadian researchers at McMaster University is developing an inhalable TB vaccine that would act as a booster to strengthen immune protection right at the site of infection — the lungs. If successful, it would be among the first new effective TB vaccines in the world.
Topic: pandemic
VIDO-InterVac wants $50 million for an additional level 4 biosafety lab to improve pandemic responsiveness
Speeding Canada’s response to future pandemics requires the highest level biosafety lab, facilities for exotic animals and more scientists. VIDO-InterVac is looking to the federal and Saskatchewan governments for funding.
Dalhousie investigator’s hunt for COVID-19 biomarkers highlights need for domestic and international research collaboration
Dr. David Kelvin in Halifax is leading an international effort to identify biomarkers for predicting the severity of COVID-19 in patients, and spearheading a collaborative network of scientists for the sharing of resources, materials and ideas.
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...